Further studies will have to focus on EphB4 mediated effects using different glioma cell lines and loss of function approaches to characterize EphB4 signaling depending on the oncobiological context to support clinical translation of EphB4 as a potential target in glioma resistance. Here, EPHB4 is linked to glioma.